ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,595Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 1499

$1.47M Total Retail Price of All Prescriptions

Rank: 22 out of 1499

990 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 990 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 990 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 22,181 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
FUROSEMIDE 1,246 998 1 7
HYDROCODONE-ACETAMINOPHEN 974 668 S3 2 4
LEVOTHYROXINE SODIUM 943 769 3 2
SIMVASTATIN 899 700 4 3
LISINOPRIL 868 553 5 1
OMEPRAZOLE 800 560 6 5
AMLODIPINE BESYLATE 703 505 7 6
METFORMIN HCL 683 525 8 8
PRAVASTATIN SODIUM 618 518 9 18
METOPROLOL TARTRATE 573 440 10 10
CITALOPRAM HBR 489 398 11 14
GABAPENTIN 446 303 12 13
TRAZODONE HCL 427 346 13 32
WARFARIN SODIUM 421 377 14 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 417 349 15 25
ATORVASTATIN CALCIUM 392 290 16 17
RANITIDINE HCL 391 254 17 15
CRESTOR 372 321 18 34
METOPROLOL SUCCINATE 341 272 19 20
POTASSIUM CHLORIDE 322 226 20 11
MELOXICAM 296 236 21 27
DONEPEZIL HCL 283 265 22 35
LOSARTAN-HYDROCHLOROTHIAZIDE 274 232 23 73
CLONIDINE HCL 273 175 24 57
CARVEDILOL 270 162 25 22
DIOVAN HCT 262 238 26 122
HYDROCHLOROTHIAZIDE 260 174 27 9
NAMENDA 254 246 28 47
POLYETHYLENE GLYCOL 3350 254 206 28 52
LANTUS 233 135 30 46
QUETIAPINE FUMARATE 229 193 31 72
TRAMADOL HCL 226 148 32 16
SERTRALINE HCL 225 163 33 24
TRAMADOL HCL-ACETAMINOPHEN 217 175 34 162
DIOVAN 215 150 35 58
EXELON 185 179 36 166
ALLOPURINOL 184 163 37 36
ATENOLOL 178 140 38 21
DIGOXIN 172 166 39 56
PAROXETINE HCL 171 151 40 59
HYDRALAZINE HCL 169 154 41 118
DILTIAZEM 24HR CD 167 149 42 82
CYMBALTA 163 71 43 40
VERAPAMIL ER 156 131 44 117
GLIMEPIRIDE 154 129 45 38
MEGESTROL ACETATE 153 153 R 46 202
PANTOPRAZOLE SODIUM 152 132 47 48
MIRTAZAPINE 149 117 48 50
TAMSULOSIN HCL 147 136 49 29
RISPERIDONE 142 92 50 74
GLYBURIDE-METFORMIN HCL 142 137 R 50 165
FLUTICASONE PROPIONATE 141 85 52 31
DIVALPROEX SODIUM 137 52 53 100
CLOPIDOGREL 132 122 54 39
LIPITOR 130 77 55 107
SPIRONOLACTONE 130 110 55 61
CEPHALEXIN 125 91 57 83
ADVAIR DISKUS 125 60 57 37
FENOFIBRATE 122 91 59 66
NIFEDIPINE ER 122 93 59 156
AZITHROMYCIN 120 98 61 45
SEROQUEL 119 100 62 158
NOVOLOG 117 110 63 110
ESCITALOPRAM OXALATE 116 108 64 76
CIPROFLOXACIN HCL 115 101 65 65
SPIRIVA 113 81 66 44
GLIPIZIDE 112 99 67 64
FLUOXETINE HCL 106 64 68 43
ALENDRONATE SODIUM 105 86 69 33
SINGULAIR 105 62 69 67
PROAIR HFA 104 58 71 30
SYMBICORT 104 56 71 121
AMITRIPTYLINE HCL 104 76 R 71 49
LOVASTATIN 102 80 74 19
ZOLPIDEM TARTRATE 101 66 75 23
PLAVIX 98 86 76 54
DILTIAZEM ER 97 95 77 124
VYTORIN 97 97 77 154
JANUVIA 97 76 77 84
AMIODARONE HCL 96 78 80 231
ABILIFY 94 58 81 143
LEVEMIR 92 73 82 243
BENAZEPRIL HCL 89 84 83 93
PHENYTOIN SODIUM EXTENDED 89 55 83 137
NYSTATIN 86 58 85 146
NEXIUM 85 34 86 28
FINASTERIDE 84 80 87 98
CELEBREX 84 50 87 77
FAMOTIDINE 81 58 89 86
KLOR-CON M20 79 57 90 97
PRENATAL PLUS 78 19 91 157
SULFAMETHOXAZOLE-TRIMETHOPRIM 76 64 92 87
PROPRANOLOL HCL 76 40 92 115
ZETIA 73 35 94 91
NAPROXEN 72 50 95 63
ISOSORBIDE MONONITRATE ER 71 63 96 51
ROPINIROLE HCL 71 53 96 55
OLANZAPINE 69 52 98 140
INSULIN SYRINGE 66 47 99 102
CARBIDOPA-LEVODOPA 66 66 99 92
LOSARTAN POTASSIUM 66 44 99 26
LIDODERM 65 41 102 123
LEXAPRO 63 54 103 209
BYSTOLIC 62 40 104 108
LORAZEPAM 62 62 104 378
HUMALOG 61 35 106 193
TRIAMCINOLONE ACETONIDE 61 53 106 126
TOPIRAMATE 60 0 108 128
AMOXICILLIN 59 33 109 113
PREDNISONE 58 46 110 42
METFORMIN HCL ER 57 34 111 53
CYCLOBENZAPRINE HCL 57 16 R 111 41
LEVEMIR FLEXPEN 56 45 113 235
AMLODIPINE BESYLATE-BENAZEPRIL 55 55 114 109
NITROFURANTOIN MONO-MACRO 55 40 114 188
LYRICA 55 22 114 90
VESICARE 53 39 117 180
COLESTIPOL HCL 53 53 117 293
IBUPROFEN 53 0 117 70
IPRATROPIUM-ALBUTEROL 52 51 120 161
VENLAFAXINE HCL ER 51 35 121 96
LEVOFLOXACIN 51 36 121 101
HYDROXYZINE HCL 50 25 R 123 173
COMBIVENT 50 34 123 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.